FiColla

Bones & Joints

 

FiColla is highly beneficial for Bones & Joints, offering natural support for overall joint health and mobility. Rich in essential amino acids, these peptides help stimulate collagen production in the body, promoting stronger cartilage and reducing joint discomfort. Additionally, they enhance bone density by supporting the mineralization process, making them a vital component in maintaining healthy, resilient bones as we age. Regular intake of FiColla can help improve flexibility, reduce stiffness, and support an active lifestyle.

WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index)

WOMAC is a scale for Assessing pain, stiffness, and physical function in people with hip or knee osteoarthritis.

WOMAC Score from Visit 1 through Visit 3

  • 86.21% of subjects reached the end point for WOMAC after 90 days of treatment with FiColla (Fish Collagen peptide).
    (Z = 3.90, p = 0.000 < 0.05).

 

Reduction in WOMAC Score from Baseline to End of Study

  • The end point is a reduction of >10 scores. However, the average reduction in scores was 21.90 in the WOMAC scale, assessing joint pain, stiffness, and physical function after 90 days of treatment with FiColla (Fish Collagen Peptide). This is almost twice of the end point set for the assessment. (t = 6.31, p = 0.000 < 0.05).

 

WOMAC : Average Scores

 

Pain Scale - PAIN Score from Visit 1 through Visit 3

  • Pain NRS scale of 0-10 where 0 = no pain and 10 = worst pain

 

  • 82.76% of subjects reported reduction in pain after 90 days of treatment with FiColla (Fish Collagen Peptide).
    (Z = 3.53, p = 0.000 < 0.05).

 

Reduction in PAIN Score from Baseline to End of Study

  • The end point is a reduction of >2 scores. The average resolution on the Pain NRS scale is 3.34 after 90 days of treatment with FiColla (fish collagen peptide). (t = 4.63, p = 0.000 < 0.05).

 

PAIN VAS : Average Scores

 

Global Rating of Change Scale : Based on X-Ray

  • 93.10% of subjects showed improvement in X-ray after 90 days of treatment with FiColla (Fish Collagen Peptide),
    (Z = 4.27, p = 0.000 < 0.05).

 

  • The end point is reduction of >2 scores. The average improvement score was 2.34 on the Global Rating of Change Scale as assessed by the physical based on the improvement in the X-ray after 90 days of treatment with FiColla (Fish Collagen Peptide).(t = 3.00, p = 0.002 < 0.05).

GRS Score at Visit 3

IP Feedback Questionnaire : Feedback About FiColla (Fish Collagen Peptide)

  • 89.66% of subjects reported they were very satisfied after 90 days of treatment with FiColla (Fish Collagen Peptide).
    (Z = 4.27, p = 0.000 < 0.05).

 

  • The end point is a total score of >15 scores. The average score in the IP Feedback Questionnaire expressing their satisfaction with FiColla (Fish Collagen Peptide) after 90 days of treatment was  19.48.(t = 7.10, p = 0.000 < 0.05).

IPFBQ Score at Visit 3

IP Feedback Questionnaire

 

Assessment Parameters

  • 51.72% of subjects rated the taste of FiColla (Fish Collagen Peptide) as good.

 

  • 51.72% of subjects rated the aftertaste of FiColla (Fish Collagen Peptide) as good.

 

  • 68.97% of subjects rated the ease/convenience of using FiColla (Fish Collagen Peptide) as very good.

 

  • 55.17% of subjects rated the improvement in the quality of life after using FiColla (Fish Collagen Peptide) as excellent.

 

  • 51.72% of subjects rated the overall satisfaction of treatment with FiColla (Fish Collagen Peptide) as excellent.

Conclusion

  • WOMAC is a subjective questionnaire that assessed pain, stiffness and physical function between baseline and 90 days after treatment with Ficolla (Fish Collagen Peptide). 86.21% of subjects have reached the end point ie shown reduction in pain, stiffness in joints and improvement in physical function.

 

  •  Pain scale rates pain in joints on a scale of 0-10. 0=no pain and 10=worst pain. 82.76% of subjected reported reduction of joint pain by 2 points after treatment with Ficolla (Fish Collagen Peptide) for 90 days.

 

  • Global rating of change scale is assessed by the Investigator to evaluate improvement in the X-Ray of Target Joint before and after 90 days of treatment with Ficolla (Fish Collagen Peptide). 93.10% of subjects have shown improvement in X-Ray evaluation

 

  • IP Feedback Questionnaire is a self reported questionnaire designed specifically for this study to capture the subjective feedback regarding the investigational product. 89.66% of subjects provided excellent feedback after 90 days of treatment with Ficolla (Fish Collagen Peptide)

 

Hence, upon statistical analysis of the clinical study, FiColla (Fish Collagen Peptide) is recommended as a safe, clinically verified and validated nutraceutical supplement for improvement in joint pain in adults.